• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, August 2, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Science

SLAS Discovery announces its June cover article

Bioengineer by Bioengineer
May 20, 2019
in Science
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

SLAS Discovery announces its June cover article, ‘A Perspective on Extreme Open Science: Companies Sharing Compounds without Restriction’

IMAGE

Credit: David James Group

Oak Brook, IL – The June cover of SLAS Discovery features cover article “A Perspective on Extreme Open Science: Companies Sharing Compounds without Restriction,” by Timothy M. Willson, Ph.D., a noted University of North Carolina Eshelman School of Pharmacy (Chapel Hill, NC, USA) Research Professor and Chief Scientific Officer for the Structural Genomics Consortium (SGC) (Oxford, UK).

The article focuses on how the validation of new targets for drug discovery remains a considerable hurdle to the exploration of new and innovative medicines. For instance, although the human genome sequence was published over 15 years ago, the biological role of most of the proteins it encodes is still not known or even studied. Dr. Willson and his team outline their experience with the open sharing of small molecule kinase inhibitors as a disruptive approach to explore the biology of some of these “dark proteins.” Therefore, by leveraging the pooled knowledge of the scientific community, several dark kinases have emerged as potential drug targets.

Furthermore, the principles of open science often present challenges for pharmaceutical and other for-profit companies due to their conventional research and intellectual property practices, especially when small molecules are involved. Working within GlaxoSmithKline, Dr. Willson and his colleagues overcame these obstacles by creating a chemogenomic set of published kinase inhibitors in which they gained support for the open sharing of the compounds. Their critical argument was that the public data generated by use of the inhibitors would “bake a bigger pie” of knowledge from which the company could initiate internal drug discovery projects.

“GlaxoSmithKline was a pioneer in the unrestricted sharing of kinase inhibitors to support basic research,” says Dr. Willson. “Now we are seeing many more pharmaceutical companies making small molecule tools openly available to the research community through our SGC laboratories.”

Access to June’s SLAS Discovery special issue is available at https://journals.sagepub.com/toc/jbxb/24/5 through June 20. For more information about SLAS and its journals, visit http://www.slas.org/journals.

###

SLAS (Society for Laboratory Automation and Screening) is an international community of 19,000 professionals and students dedicated to life sciences discovery and technology. The SLAS mission is to bring together researchers in academia, industry and government to advance life sciences discovery and technology via education, knowledge exchange and global community building.

SLAS Discovery: 2017 Impact Factor 2.355. Editor-in-Chief Robert M. Campbell, Ph.D., Eli Lilly and Company, Indianapolis, IN (USA). SLAS Discovery (Advancing Life Sciences R&D) was previously published (1996-2016) as the Journal of Biomolecular Screening (JBS).

SLAS Technology: 2017 Impact Factor 2.632. Editor-in-Chief Edward Kai-Hua Chow, Ph.D., National University of Singapore (Singapore). SLAS Technology (Translating Life Sciences Innovation) was previously published (1996-2016) as the Journal of Laboratory Automation (JALA).

Media Contact
Jill Hronek
[email protected]

Original Source

https://www.slas.org/media/news-center/2019-news-releases/junes-slas-discovery-cover-article-now-available/

Tags: BiochemistryBiomedical/Environmental/Chemical EngineeringBiotechnologyHealth CareMedicine/HealthMolecular BiologyPharmaceutical ChemistryPharmaceutical Sciences
Share12Tweet8Share2ShareShareShare2

Related Posts

Five or more hours of smartphone usage per day may increase obesity

July 25, 2019
IMAGE

NASA’s terra satellite finds tropical storm 07W’s strength on the side

July 25, 2019

NASA finds one burst of energy in weakening Depression Dalila

July 25, 2019

Researcher’s innovative flood mapping helps water and emergency management officials

July 25, 2019
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    45 shares
    Share 18 Tweet 11
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    38 shares
    Share 15 Tweet 10

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Amyloid Fibrils Connect CHCHD10, CHCHD2 to Neurodegeneration

Mapping the Human Hippocampus: Single-Nucleus to Spatial Transcriptomics

Composable Key Distribution via Discrete-Modulated CV Quantum Cryptography

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.